US4526869A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for quantitatively determining the concentration of hemoglobin in a biological sample
Assignee: University of Minnesota Twin Cities
•
Filing: 1983-03-31
•
Granted: 1985-07-02
•
Expires: 2003-03-31
Abstract
Abstract A method for quantitatively determining the amount of hemoglobin in feces, urine or gastric juice comprising the steps of preparing a test sample of the feces, urine or gastric juice, converting the hemoglobin in the test sample to porphyrin with a converting reagent which is acidic and which has a reducing capacity sufficient to convert substantially all or a reproducible portion of the hemoglobin to porphyrin and determining the level of porphyrin in the test sample.
Inventors
- 👤 Samuel Schwartz
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 13:46
CPC Classifications
A; A61; A61B; A61B10/00; A61B10/0038; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
103 words
A method of quantitatively determining the amount of hemoglobin in feces, urine or gastric juices comprising the steps of: preparing a test sample of feces, urine or gastric juices; converting hemoglobin in said test sample to porphyrin by combining said test sample with an acidic converting reagent, said converting reagent being selected from the group of converting reagents having a reducing capacity sufficient to convert the hemoglobin in said test sample to porphyrin so that said conversion is substantially linear for concentrations of hemoglobin as high as 40 micrograms of hemoglobin per milliliter; and determining the level of porphyrin in said test sample.
Claim 2
Independent Claim
103 words
A method of quantitatively determining the amount of hemoglobin in feces, urine or gastric juices comprising the steps of: preparing a test sample of feces, urine or gastric juices; converting hemoglobin in said test sample to porphyrin by combining said test sample with an acidic converting reagent, said converting reagent being selected from the group of converting reagents having a reducing capacity sufficient to convert the hemoglobin in said test sample to porphyrin so that said conversion is substantially linear for concentrations of hemoglobin as high as 40 micrograms of hemoglobin per milliliter; and determining the level of porphyrin in said test sample.
Claim 3
Dependent Claim
33 words
The method of claim 1 wherein said steps of preparing a test sample and converting the hemoglobin in said test sample to porphyrin includes diluting said test sample to form a diluted solution.
Claim 4
Dependent Claim
12 words
The method of claim 1 including substantially isolating the porphyrin from contaminants.
Claim 5
Dependent Claim
25 words
The method of claim 1 including heating said combined test sample and converting reagent to a temperature of between about 80° C. and 120° C.
Claim 6
Dependent Claim
16 words
The method of claim 1 wherein the level of porphyrin is determined by a fluorescence assay.
Claim 7
Dependent Claim
21 words
The method of claim 1 wherein said converting reagent has a reducing capacity sufficient to convert substantially all of the hemoglobin.
Claim 8
Dependent Claim
46 words
The method of claim 1 wherein said converting reagent is selected to have a reducing capacity sufficient to convert the hemoglobin in said sample to porphyrin so that said conversion is substantially linear for concentrations of hemoglobin as high as 100 micrograms of hemoglobin per milliliter.
Claim 9
Dependent Claim
17 words
The method of claim 1 wherein said converting reagent has a pH of no more than 2.
Claim 10
Dependent Claim
77 words
The method of claim 8 wherein said converting reagent includes the combination of: an acid component comprised of one or more of the compounds selected from the group consisting of oxalic acid, ascorbic acid, formic acid, sulfuric acid, hydrochloric acid, phosphoric acid, hypophosphorus acid and orthophosphorus acid; and a reducing component comprised of one or more of the compounds selected from the group consisting of ferrous salts, manganous salts, stannous salts, cobaltous salts, nickel salts and dithiothreitol.
Claim 11
Dependent Claim
32 words
The method of claim 1 including the adding a second reagent to said combined test sample and converting reagent for reacting with free radicals formed during the conversion of hemoglobin to porphyrin.
Claim 12
Dependent Claim
14 words
The method of claim 10 wherein said second reagent includes uric acid and mannitol.
Claim 13
Independent Claim
95 words
A method of quantitatively determining the amount of hemoglobin in feces comprising the steps of: preparing a test sample of feces; converting hemoglobin in said test sample to porphyrin by combining said test sample with an acidic converting reagent, said converting reagent being selected from the group of converting reagents having a reducing capacity sufficient to convert the hemoglobin in said test sample to porphyrin so that said conversion is substantially linear for concentrations of hemoglobin as high as 40 micrograms of hemoglobin per milliliter; and determining the level of porphyrin in said test sample.
Claim 14
Independent Claim
95 words
A method of quantitatively determining the amount of hemoglobin in feces comprising the steps of: preparing a test sample of feces; converting hemoglobin in said test sample to porphyrin by combining said test sample with an acidic converting reagent, said converting reagent being selected from the group of converting reagents having a reducing capacity sufficient to convert the hemoglobin in said test sample to porphyrin so that said conversion is substantially linear for concentrations of hemoglobin as high as 40 micrograms of hemoglobin per milliliter; and determining the level of porphyrin in said test sample.
Claim 15
Dependent Claim
77 words
The method of claim 12 wherein said converting reagent includes a combination of: an acid component comprised of one or more of the compounds selected from the group consisting of oxalic acid, ascorbic acid, formic acid, sulfuric acid, hydrochloric acid, phosphoric acid, hypophosphorous acid and orthophosphorous acid; and a reducing component comprised of one or more of the compounds selected from the group consisting of ferrous salts, manganous salts, stannous salts, cobaltous salts, nickel salts and dithiothreitol.
Claim 16
Dependent Claim
33 words
The method of claim 12 wherein said steps of preparing a test sample and converting the hemoglobin in said test sample to porphyrin includes diluting said test sample to form a diluted solution.
Claim 17
Dependent Claim
25 words
The method of claim 12 including heating said combined test sample and converting reagent to a temperature of between about 80° C. and 120° C.
Claim 18
Dependent Claim
16 words
The method of claim 12 wherein the level of porphyrin is determined by a fluorescence assay.
Claim 19
Dependent Claim
21 words
The method of claim 12 wherein said converting reagent has a reducing capacity sufficient to convert substantially all of the hemoglobin.
Claim 20
Dependent Claim
47 words
The method of claim 12 wherein said converting reagent is selected to have a reducing capacity sufficient to convert the hemoglobin in said test sample to porphyrin so that said conversion is substantially linear for concentrations of hemoglobin as high as 100 micrograms of hemoglobin per milliliter.
Claim 21
Dependent Claim
17 words
The method of claim 12 wherein said converting reagent has a pH of no more than 2.
Claim 22
Dependent Claim
81 words
The method of claim 19 wherein said converting reagent includes a combination of: an acid component comprised of one or more of the compounds selected from the group consisting of oxalic acid, ascorbic acid, formic acid, sulfuric acid, hydrochloric acid, phosphoric acid, hypophosphorous acid and orthophosphorous acid; and a reducing component comprised of one or more of the compounds selected from the group consisting of ferrous salts, manganous salts, stannous salts, cobaltous salts, nickel salts and dithiothreitol acid and orthophosphorous acid.
References Cited (Backward Citations)
US2290436A
Cited
US2838377A
Cited
US3012976A
Cited
US3092464A
Cited
US3092463A
Cited
US3252762A
Cited
US3290117A
Cited
US3692410A
Cited
US3663175A
Cited
US3718431A
Cited
US3874852A
Cited
US3874852B1
Cited
US4017261A
Cited
US3936373A
Cited
US3964865A
Cited
US4005984A
Cited
US4035150A
Cited
US4063894A
Cited
US4092120A
Cited
US4219336A
Cited
US4199550A
Cited
US4175923A
Cited
US4378971A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-07-01 | 1988-12-31 | 1989-07-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-07-01 | 1992-12-31 | 1993-07-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-07-01 | 1996-12-31 | 1997-07-02 | $7700.00 | Window Closed / Lapsed |